• Neurocrine Biosciences average ebitda margin for 2023 was 11.48%, a 4.27% increase from 2022.
• Neurocrine Biosciences average ebitda margin for 2022 was 11.01%, a 31.95% increase from 2021.
• Neurocrine Biosciences average ebitda margin for 2021 was 16.18%, a 31.18% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.